PENGARUH TOTAL ASET DAN VOLUME PENJUALAN MELALUI LABA BERSIH TERHADAP HARGA SAHAM PADA SUB SEKTOR FARMASI YANG TERDAFTAR DI BURSA EFEK INDONESIA PERIODE 2016-2022

Resti Juliana, 2000861201100 (2024) PENGARUH TOTAL ASET DAN VOLUME PENJUALAN MELALUI LABA BERSIH TERHADAP HARGA SAHAM PADA SUB SEKTOR FARMASI YANG TERDAFTAR DI BURSA EFEK INDONESIA PERIODE 2016-2022. skripsi thesis, Universitas BATANGHARI Jambi.

	Text 01. COVER.pdf - Published Version Download (47kB)
	Text 02. LEMBAR PENGESAHAN.pdf - Published Version Download (381kB)
	Text 03. ABSTRACT.pdf - Published Version Download (194kB)
	Text 06. BAB I.pdf - Published Version Download (218kB)
	Text 10. BAB V.pdf - Published Version Download (100kB)
	Text 11. DAFTAR PUSTAKA.pdf - Published Version Download (177kB)
	Text (PENGARUH TOTAL ASET DAN VOLUME PENJUALAN MELALUI LABA BERSIH TERHADAP HARGA SAHAM PADA SUB SEKTOR FARMASI YANG TERDAFTAR DI BURSA EFEK INDONESIA PERIODE 2016-2022) Resti Juliana 2000861201100.pdf - Published Version Restricted to Repository staff only Download (2MB)

Abstract

The purpose of this study is to be able to analyze and know the effect of total assets and sales volume through net income on stock prices in the pharmaceutical sector listed on the Indonesia Stock Exchange for the period 2016–2022. And be able to simultaneously and partially analyze the effect of total assets and sales volume through net income on stock prices in the pharmaceutical sector listed on the Indonesia Stock Exchange for the period 2016–2022. The source of data in this research is the official website of the Indonesian Stock Exchange. In this study, analytical tools are used: path analysis, normality tests, and hypothesis testing (F test, T test). From the normality test results, it can be concluded that the residuals are normally distributed at 0,200 > 0,5. Researchers select pharmaceutical sub-sector industry companies that are already registered on the Indonesia Stock Exchange (IDX), as many as six companies. Researchers chose this subsector because medicines are increasingly needed as the Indonesian population grows. Both now and in the future, the prospects of pharmaceutical companies are predicted to grow rapidly. This is supported by increased awareness of the importance of health and increased access to health care. The result of the research shows that total assets and sales volume simultaneously have a positive and significant effect on net income, and total assets and sales volume simultaneously have a positive and significant effect on stock price. total assets Partially has a positive and significant effect on net income; sales volume partially has a negative and significant effect on net income. Total assets and sales volume simultaneously have a positive and significant effect on stock prices. total assets Partially has a positive, no significant effect on stock prices; sales volume partially has a negative, no significant effect on stock prices. Net income has a significant positive impact on stock prices. The result of the path analysis test is that the total effect of total assets and sales volume on stock prices through the net income is 0.64%, so it can be concluded that the net income mediates the effect of total assets and sales volume on stock prices in the pharmaceutical sub-sector industry listed on the Indonesia Stock Exchange for the period 2016–2022.

Actions (login required)

View Item